Literature DB >> 19178495

Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.

Sally E de Zwaan1, Harry J Iland, Diona L Damian.   

Abstract

We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19178495     DOI： 10.1111/j.1440-0960.2008.00506.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  8 in total

1.  [Surgical management of Pyoderma gangrenosum].

Authors:  I Sick; B Trautner; T Ruzicka
Journal:  Hautarzt       Date:  2012-07       Impact factor: 0.751

Review 2.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

3.  Pyoderma gangrenosum of the breast treated with intravenous immunoglobulin.

Authors:  Sudipta Sinnya; Saud Hamza
Journal:  J Dermatol Case Rep       Date:  2013-06-30

Review 4.  Management of pyoderma gangrenosum.

Authors:  Alexandra Teagle; Rachel Hargest
Journal:  J R Soc Med       Date:  2014-06-09       Impact factor: 5.344

5.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01

Review 6.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

7.  Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature.

Authors:  John Cafardi; Naveed Sami
Journal:  Case Rep Dermatol       Date:  2014-10-23

Review 8.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.